- Home
- PDCO vs HRMY Comparison
PDCO vs HRMY Comparison
Compare PDCO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDCO
- HRMY
- Stock Information
- Founded
- PDCO 1877
- HRMY 2017
- Country
- PDCO United States
- HRMY United States
- Employees
- PDCO N/A
- HRMY N/A
- Industry
- PDCO Medical Specialities
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PDCO Health Care
- HRMY Health Care
- Exchange
- PDCO Nasdaq
- HRMY Nasdaq
- Market Cap
- PDCO 2.7B
- HRMY 1.9B
- IPO Year
- PDCO 1992
- HRMY 2020
- Fundamental
- Price
- PDCO $30.82
- HRMY $34.83
- Analyst Decision
- PDCO Hold
- HRMY Buy
- Analyst Count
- PDCO 7
- HRMY 10
- Target Price
- PDCO $27.10
- HRMY $49.80
- AVG Volume (30 Days)
- PDCO 2.0M
- HRMY 539.5K
- Earning Date
- PDCO 02-26-2025
- HRMY 02-20-2025
- Dividend Yield
- PDCO 3.37%
- HRMY N/A
- EPS Growth
- PDCO N/A
- HRMY N/A
- EPS
- PDCO 1.72
- HRMY 2.11
- Revenue
- PDCO $6,554,872,000.00
- HRMY $681,879,000.00
- Revenue This Year
- PDCO $2.81
- HRMY $24.83
- Revenue Next Year
- PDCO $2.87
- HRMY $18.66
- P/E Ratio
- PDCO $17.87
- HRMY $16.53
- Revenue Growth
- PDCO 0.05
- HRMY 25.83
- 52 Week Low
- PDCO $19.45
- HRMY $28.14
- 52 Week High
- PDCO $31.79
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PDCO 83.23
- HRMY 55.30
- Support Level
- PDCO $30.83
- HRMY $33.36
- Resistance Level
- PDCO $30.94
- HRMY $34.96
- Average True Range (ATR)
- PDCO 0.16
- HRMY 1.19
- MACD
- PDCO -0.14
- HRMY 0.16
- Stochastic Oscillator
- PDCO 7.81
- HRMY 81.62
About PDCO Patterson Companies Inc.
Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.